Intranasal alfentanil for acute pain in children [4]

Emergency Medicine Journal

Volumn 23, Issue 6, 2006, Pages 488-

  Brenchley, Jane ^a   Ramlakhan, S ^a  

^a BARNSLEY DISTRICT GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALFENTANIL; DIAMORPHINE;

ABSENCE OF SIDE EFFECTS; ADOLESCENT; CHILD; CLINICAL ARTICLE; DOSE RESPONSE; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG SAFETY; EMERGENCY CARE; FEMALE; HUMAN; LETTER; MALE; PAIN; PAIN ASSESSMENT; PREMEDICATION; PRIORITY JOURNAL; SEX RATIO; TREATMENT DURATION;

ACUTE DISEASE; ADMINISTRATION, INTRANASAL; ADOLESCENT; ALFENTANIL; ANALGESICS, OPIOID; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; MALE; PAIN;

EID: 33748585177     PISSN: 14720205     EISSN: None     Source Type: Journal    
DOI: 10.1136/emj.2005.029165     Document Type: Letter

References (4)

1. http://www.dh.gov.uk/publicationsandstatistics/pressreleases/ pressreleasenotices/fs/en?content_id=4099536&chk=gfksyg (accessed 23 December 2004).
2. Schwagmeier R, Boerger N, Meissner W, et al. Pharmacokinetics of intranasal alfentanil. J Clin Anesth 1995;7:109-13.
3. Oscengiz D, Akman H, Ozbek H, et al. Intranasal alfentanil application in children for premedication. Turk Anesteziyoloji ve Reanimasyon 1996;24:15-18.
4. Ozbek H, Ozcengiz D, Unlugenc H, et al. The effects of intranasal and intravenous alfentanil administration on postoperative pain relief. Agri 1998;10:64-7.